【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 11
1.1 List of Tables 17
1.2 List of Figures 24
2 Introduction 26
2.1 Catalyst 26
2.2 Related Reports 28
2.3 Upcoming Related Reports 28
3 Disease Overview 29
3.1 Etiology and Pathophysiology 29
3.1.1 Etiology 29
3.1.2 Pathophysiology 31
3.2 Symptoms 35
3.3 Prognosis 35
3.4 Quality of Life 35
4 Epidemiology 36
4.1 Risk Factors and Comorbidities 36
4.2 Global and Historical Trends 37
4.2.1 US 38
4.2.2 5EU 38
4.2.3 Asia 40
4.3 Forecast Methodology 41
4.3.1 Sources Used 49
4.3.2 Forecast Assumptions and Methods 55
4.3.3 Sources Not Used 81
4.4 Prevalent Cases of Dyslipidemia 82
4.4.1 Total Prevalent Cases of Dyslipidemia 82
4.4.2 Age-Specific Total Prevalent Cases of Dyslipidemia 83
4.4.3 Sex-Specific Total Prevalent Cases of Dyslipidemia 85
4.4.4 Age-Standardized Total Prevalence of Dyslipidemia 87
4.5 Epidemiological Forecast for Familial Hypercholesterolemia (2013-2023) 88
4.5.1 Total Prevalent Cases of Familial Hypercholesterolemia 88
4.6 Epidemiological Forecast for Increased LDL-C (2013-2023) 89
4.6.1 Total Prevalent Cases of Increased LDL-C 89
4.6.2 Age-Specific Total Prevalent Cases of Increased LDL-C 91
4.6.3 Sex-Specific Total Prevalent Cases of Increased LDL-C 93
4.6.4 Age-Standardized Total Prevalence of Increased LDL-C 95
4.7 Epidemiological Forecast for Very High TG (≥500mg/dL) (2013-2023) 96
4.7.1 Total Prevalent Cases of Very High TG (≥500mg/dL) 96
4.7.2 Age-Specific Total Prevalent Cases of Very High TG (≥500mg/dL) 98
4.7.3 Sex-Specific Total Prevalent Cases of Very High TG (≥500mg/dL) 100
4.7.4 Age-Standardized Total Prevalence of Very High TG (≥500mg/dL) 102
4.8 Discussion 103
4.8.1 Epidemiological Forecast Insight 103
4.8.2 Limitations of the Analysis 104
4.8.3 Strengths of the Analysis 105
5 Disease Management 106
5.1 Diagnosis and Treatment Overview 106
5.1.1 Diagnosis 106
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 108
5.1.3 Clinical Practice 111
5.2 US 113
5.3 France 117
5.4 Germany 119
5.5 Italy 122
5.6 Spain 125
5.7 UK 126
5.8 Japan 129
5.9 China 131
6 Competitive Assessment 134
6.1 Overview 134
6.2 Product Profiles – Major Brands 138
6.2.1 Statins 138
6.2.2 Zetia (ezetimibe) 158
6.2.3 Vytorin (simvastatin/ezetimibe) 167
6.2.4 Liptruzet (atorvastatin/ezetimibe) 171
6.2.5 Niaspan (niacin extended-release) 175
6.2.6 Kynamro (mipomersen sodium) 181
6.2.7 Juxtapid (lomitapide) 188
6.2.8 TriCor/Trilipix (fenofibrate/fenfibric acid) 193
6.2.9 Omega-3 Fatty Acids 198
6.2.10 Welchol (colesevelam HCl) and the Bile Acid Sequestrants 213
7 Unmet Need and Opportunity 219
7.1 Overview 219
7.2 LDL-C-Lowering Drugs for Statin-Intolerant and Statin-Refractory Patients 220
7.2.1 Unmet Need 220
7.2.2 Gap Analysis 221
7.2.3 Opportunity 222
7.3 Improved Diagnosis, Patient Education, and Long-term Compliance 223
7.3.1 Unmet Need 223
7.3.2 Gap Analysis 224
7.3.3 Opportunity 226
7.4 Therapies that Prevent or Reverse the Build-Up of Atherosclerotic Plaque 227
7.4.1 Unmet Need 227
7.4.2 Gap Analysis 228
7.4.3 Opportunity 229
7.5 Therapies for Patients with HoFH with Improved Side Effect Profiles 230
7.5.1 Unmet Need 230
7.5.2 Gap Analysis 231
7.5.3 Opportunity 232
8 Pipeline Assessment 233
8.1 Overview 233
8.2 Clinical Trial Mapping 237
8.2.1 Clinical Trials by Patient Population 237
8.3 Promising Drugs in Clinical Development 237
8.3.1 Alirocumab 237
8.3.2 Bococizumab 246
8.3.3 Evolocumab 251
8.3.4 Anacetrapib 260
8.3.5 Evacetrapib 268
8.3.6 TA-8995 (DEZ-001) 274
8.3.7 CER-001 280
8.3.8 ETC-1002 286
8.4 Other Drugs in Development 294
9 Current and Future Players 295
9.1 Overview 295
9.2 Trends in Corporate Strategy 300
9.3 Company Profiles 302
9.3.1 AbbVie 302
9.3.2 Aegerion Pharmaceuticals, Inc. 304
9.3.3 Amarin 306
9.3.4 Amgen 308
9.3.5 AstraZeneca 310
9.3.6 Cerenis Therapeutics Inc. 313
9.3.7 Daiichi Sankyo 315
9.3.8 Dezima Pharma 317
9.3.9 Eli Lilly 319
9.3.10 Esperion Therapeutics, Inc. 322
9.3.11 Genzyme 324
9.3.12 GlaxoSmithKline 326
9.3.13 Merck & Co. 328
9.3.14 Pfizer 331
9.3.15 Regeneron Pharmaceuticals, Inc. 333
9.3.16 Sanofi 335
10 Market Outlook 339
10.1 Global Markets 339
10.1.1 Forecast 339
10.1.2 Drivers and Barriers – Global Issues 348
10.2 United States 351
10.2.1 Forecast 351
10.2.2 Key Events 356
10.2.3 Drivers and Barriers 357
10.3 5EU 359
10.3.1 Forecast 359
10.3.2 Key Events 367
10.3.3 Drivers and Barriers 368
10.4 Japan 371
10.4.1 Forecast 371
10.4.2 Key Events 374
10.4.3 Drivers and Barriers 375
10.5 China 377
10.5.1 Forecast 377
10.5.2 Key Events 381
10.5.3 Drivers and Barriers 381
11 Appendix 384
11.1 Bibliography 384
11.2 Abbreviations 412
11.3 Methodology 420
11.4 Forecasting Methodology 420
11.4.1 Diagnosed Dyslipidemia Patients 420
11.4.2 Percent Drug-Treated Patients 421
11.4.3 Drugs Included in Each Therapeutic Class 421
11.4.4 Launch and Patent Expiry Dates 422
11.4.5 General Pricing Assumptions 423
11.4.6 Individual Drug Assumptions 424
11.4.7 Generic Erosion 431
11.4.8 Pricing of Pipeline Agents 431
11.5 Physicians and Specialists Included in this Study 432
11.6 About the Authors 434
11.6.1 Analyst 434
11.6.2 Therapy Area Director 435
11.6.3 Epidemiologist 435
11.6.4 Global Head of Healthcare 436
11.7 About GlobalData 437
11.8 Disclaimer 437
【レポート販売概要】
■ タイトル：脂質異常症治療薬の世界市場予測および分析■ 英文：PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2015年5月5日
■ 調査会社：GlobalData
■ 商品コード：GDHC110PIDR
■ 調査対象地域：グローバル
- 消化器内視鏡の世界市場2016-2020About Gastrointestinal Endoscopy DevicesThe endoscopes used to inspect the internal lining of the GI tract are known as GI endoscopic devices. The diagnosis of GI tract includes large intestine, stomach, duodenum, small intestine, colon, and rectum. Any abnormalities or infection in function of this GI tract is detected by using GI endoscope devices. These devices help in detecting the cause of vo …
- Tradjenta (Type 2 Diabetes)：市場予測と分析（～2022）Tradjenta (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Tradjenta (Type 2 Diabetes) - Forecast and Market Analysis to 2022". The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, …
- 世界の軍用固定翼航空機の市場動向2013-2023：市場のSWOT分析This SWOT analysis of Military Fixed-Wing Aircraft market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Military Fixed-Wing Aircraft Market 2013-2023 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible …
- 医療機器業界のM&A及び投資動向（月別）：April 2013Medical Equipment Monthly Deals Analysis: April 2013 - M&A and Investment Trends Summary GlobalData's “Medical Equipment Monthly Deals Analysis: April 2013 - M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerin …
- 化粧品/香水用ガラスびんの世界市場2015-2019About cosmetic and perfume glass bottles Packaging constitutes an important part of the functionality and esthetics of cosmetic and perfumery products and can affect the effectiveness of the formulation and quality of the contained product. Considering the technical superiority of glass as a material, molded glass bottles are widely used in the cosmetics and perfumery industry. From a marketing pe …
- 世界の輸液ポンプ市場：インスリンポンプ、経腸栄養ポンプInfusion pumps – new study showing you trends, R&D progress, and predicted revenues Where is the infusion pumps market heading? Visiongain’s brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 216-page report provides 127 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. O …
- スペインの移動補助・運搬機器市場見通し（～2021）Spain Mobility Aids and Transportation Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Spain Mobility Aids and Transportation Equipment Market Outlook to 2021", provides key market data on the Spain Mobility Aids and Transportation Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segme …
- ビックデータ分野のリーディング企業分析：InformaticaBig Data represents a collection of data sets so large and complex that it becomes difficult to process using on-hand database management tool. It is also unstructured, meaning that it is not tabulated, correlated, etc. (e.g. it does not have a pre-defined data model or is not organized in a pre-defined manner). Big Data technologies enable organizations to handle huge datasets and generate inform …
- 新興国のオーバーザトップ（OTT）ビデオ市場Summary “OTT Video in Emerging Markets: Monetization Strategies and 5-Year Revenue Opportunity,” a Research Report by Pyramid Research, analyzes the revenue potential of OTT video services across emerging markets in Africa and the Middle East, Asia Pacific, Central and Eastern Europe, and Latin America, identifying and mapping key OTT video players from local telcos and payTV providers to pure-pla …
- セット トップ ボックス（STB）の将来In recent years, television STBs have experienced many changes related to the ever-growing supply of digital TV services and the profound changes we are seeing in how video is consumed. With the growth of IP and competitive OTT offerings, technological advances in both software and hardware, and the emergence of new competitors, the future role of STBs in homes is now under scrutiny. IDATE reports …
- 分子診断の世界市場2016-2020About Molecular Diagnostics The traditional trial and error techniques that were used in the field of medicine are now being replaced by accurate, safe, marker-assisted, molecular-guided treatments. Molecular diagnostics is one such technique. This is a technique that involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of perfo …
- 臨床試験イメージングの世界市場：CT、MRI、PET、超音波、心エコー、X線The global clinical trials imaging market is expected to USD 981.53 million by 2020 from USD 724.87 million in 2015, at a CAGR of 6.25% between 2015 and 2020. By product, the market includes services & software. The services product segment is further classified into operational imaging services, systems & technology, reader services & design consulting. Based on modality, the market is segmented …
- dPCR（デジタルポリメラーゼ連鎖反応）の世界市場2017-2021ABSTRACTAbout dPCR Digital polymerase chain reaction (dPCR) technology is an advanced version of the polymerase chain reaction (PCR) technology that enables users to amplify and directly quantify nucleic acids, such as DNA, RNA, cDNA, and methylated DNA with a high level of precision. The technique allows users to statistically analyze PCR products by converting exponential, analog signals obtaine …
- Asia Power Corporation Limited：発電所及びSWOT分析2013Asia Power Corporation Limited - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - sum …
- イソプレンの世界市場予測（～2021年）：ポリイソプレン、スチレン−イソプレン−スチレン、イソブチルイソプレンゴム“The isoprene market is expected to grow at a CAGR of 7.4% during forecast period”The isoprene market is projected to reach USD 2.96 billion by 2021, at a CAGR of 7.4% from 2016 to 2021. Isoprene is a colorless volatile liquid obtained by thermal cracking of naphtha and other petrochemicals. Isoprene either alone or in combination with other compounds is primarily used to make polymeric materials. …
